Jianzhen R. Shen
National Key Laboratory Of Hematology, Fujian Medical University Union Hospital
Fuzhou, China
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.
Journal: Nature communications
Published: December 24, 2025
Clinical perception and novel insights of chronic myelomonocytic leukemia: a 10-year multi-center retrospective study.
Journal: Frontiers in medicine
Published: September 23, 2025
Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma.
Journal: Human genomics
Published: August 26, 2025
LncRNA NEAT1 restrains the malignant biological characteristics of acute myeloid leukemia via regulating CTCF/CXCR2 axis.
Journal: Clinical and experimental medicine
Published: August 11, 2025
Clinical management and outcomes of respiratory distress syndrome in preterm infants <32 weeks' gestation from the Chinese Neonatal Network from 2019 to 2023
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: July 22, 2025
Novel insights and clinical perception of the patients with acute leukemia transferred to ICU: a multi-center retrospective study spanning 10 years.
Journal: Frontiers in medicine
Published: July 01, 2025
Long noncoding RNA ADEI/miR-93-3p/STAT3 axis promotes Epstein-Barr virus-positive diffuse large B-cell lymphoma progression and immune evasion through regulating the PD-1/PD-L1 checkpoint.
Journal: Cell death & disease
Published: June 29, 2025
Research progress in using human organoid platforms to study enteroviruses infection
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: June 15, 2025
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 study.
Journal: Signal transduction and targeted therapy
Published: May 19, 2025
Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
Journal: Journal of hepatocellular carcinoma
Published: May 07, 2025
A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma.
Journal: Journal of hematology & oncology
Published: February 17, 2025
Last Updated: 09/26/2026